Global HER2 Targeted Therapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global HER2 Targeted Therapy Market Size 2017-2028

2.1.2 HER2 Targeted Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 HER2 Targeted Therapy Segment by Type

2.2.1 Monotherapy

2.2.2 Combination Therapy

2.2.3 Others

2.3 HER2 Targeted Therapy Market Size by Type

2.3.1 HER2 Targeted Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global HER2 Targeted Therapy Market Size Market Share by Type (2017-2022)

2.4 HER2 Targeted Therapy Segment by Application

2.4.1 Breast Cancer

2.4.2 Stomach Cancer

2.4.3 Head and Neck Cancer

2.4.4 Lung Cancer

2.4.5 Ovarian Cancer

2.4.6 Others

2.5 HER2 Targeted Therapy Market Size by Application

2.5.1 HER2 Targeted Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global HER2 Targeted Therapy Market Size Market Share by Application (2017-2022)

3 HER2 Targeted Therapy Market Size by Player

3.1 HER2 Targeted Therapy Market Size Market Share by Players

3.1.1 Global HER2 Targeted Therapy Revenue by Players (2020-2022)

3.1.2 Global HER2 Targeted Therapy Revenue Market Share by Players (2020-2022)

3.2 Global HER2 Targeted Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 HER2 Targeted Therapy by Regions

4.1 HER2 Targeted Therapy Market Size by Regions (2017-2022)

4.2 Americas HER2 Targeted Therapy Market Size Growth (2017-2022)

4.3 APAC HER2 Targeted Therapy Market Size Growth (2017-2022)

4.4 Europe HER2 Targeted Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa HER2 Targeted Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas HER2 Targeted Therapy Market Size by Country (2017-2022)

5.2 Americas HER2 Targeted Therapy Market Size by Type (2017-2022)

5.3 Americas HER2 Targeted Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC HER2 Targeted Therapy Market Size by Region (2017-2022)

6.2 APAC HER2 Targeted Therapy Market Size by Type (2017-2022)

6.3 APAC HER2 Targeted Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe HER2 Targeted Therapy by Country (2017-2022)

7.2 Europe HER2 Targeted Therapy Market Size by Type (2017-2022)

7.3 Europe HER2 Targeted Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa HER2 Targeted Therapy by Region (2017-2022)

8.2 Middle East & Africa HER2 Targeted Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa HER2 Targeted Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global HER2 Targeted Therapy Market Forecast

10.1 Global HER2 Targeted Therapy Forecast by Regions (2023-2028)

10.1.1 Global HER2 Targeted Therapy Forecast by Regions (2023-2028)

10.1.2 Americas HER2 Targeted Therapy Forecast

10.1.3 APAC HER2 Targeted Therapy Forecast

10.1.4 Europe HER2 Targeted Therapy Forecast

10.1.5 Middle East & Africa HER2 Targeted Therapy Forecast

10.2 Americas HER2 Targeted Therapy Forecast by Country (2023-2028)

10.2.1 United States HER2 Targeted Therapy Market Forecast

10.2.2 Canada HER2 Targeted Therapy Market Forecast

10.2.3 Mexico HER2 Targeted Therapy Market Forecast

10.2.4 Brazil HER2 Targeted Therapy Market Forecast

10.3 APAC HER2 Targeted Therapy Forecast by Region (2023-2028)

10.3.1 China HER2 Targeted Therapy Market Forecast

10.3.2 Japan HER2 Targeted Therapy Market Forecast

10.3.3 Korea HER2 Targeted Therapy Market Forecast

10.3.4 Southeast Asia HER2 Targeted Therapy Market Forecast

10.3.5 India HER2 Targeted Therapy Market Forecast

10.3.6 Australia HER2 Targeted Therapy Market Forecast

10.4 Europe HER2 Targeted Therapy Forecast by Country (2023-2028)

10.4.1 Germany HER2 Targeted Therapy Market Forecast

10.4.2 France HER2 Targeted Therapy Market Forecast

10.4.3 UK HER2 Targeted Therapy Market Forecast

10.4.4 Italy HER2 Targeted Therapy Market Forecast

10.4.5 Russia HER2 Targeted Therapy Market Forecast

10.5 Middle East & Africa HER2 Targeted Therapy Forecast by Region (2023-2028)

10.5.1 Egypt HER2 Targeted Therapy Market Forecast

10.5.2 South Africa HER2 Targeted Therapy Market Forecast

10.5.3 Israel HER2 Targeted Therapy Market Forecast

10.5.4 Turkey HER2 Targeted Therapy Market Forecast

10.5.5 GCC Countries HER2 Targeted Therapy Market Forecast

10.6 Global HER2 Targeted Therapy Forecast by Type (2023-2028)

10.7 Global HER2 Targeted Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Information

11.1.2 GlaxoSmithKline HER2 Targeted Therapy Product Offered

11.1.3 GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GlaxoSmithKline Main Business Overview

11.1.5 GlaxoSmithKline Latest Developments

11.2 Bayer

11.2.1 Bayer Company Information

11.2.2 Bayer HER2 Targeted Therapy Product Offered

11.2.3 Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Bayer Main Business Overview

11.2.5 Bayer Latest Developments

11.3 Abbott

11.3.1 Abbott Company Information

11.3.2 Abbott HER2 Targeted Therapy Product Offered

11.3.3 Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Abbott Main Business Overview

11.3.5 Abbott Latest Developments

11.4 AbbVie

11.4.1 AbbVie Company Information

11.4.2 AbbVie HER2 Targeted Therapy Product Offered

11.4.3 AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 AbbVie Main Business Overview

11.4.5 AbbVie Latest Developments

11.5 Pfizer

11.5.1 Pfizer Company Information

11.5.2 Pfizer HER2 Targeted Therapy Product Offered

11.5.3 Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Pfizer Main Business Overview

11.5.5 Pfizer Latest Developments

11.6 Sanofi

11.6.1 Sanofi Company Information

11.6.2 Sanofi HER2 Targeted Therapy Product Offered

11.6.3 Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Sanofi Main Business Overview

11.6.5 Sanofi Latest Developments

11.7 Agilent

11.7.1 Agilent Company Information

11.7.2 Agilent HER2 Targeted Therapy Product Offered

11.7.3 Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Agilent Main Business Overview

11.7.5 Agilent Latest Developments

11.8 Glenmark Pharmaceuticals

11.8.1 Glenmark Pharmaceuticals Company Information

11.8.2 Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered

11.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Glenmark Pharmaceuticals Main Business Overview

11.8.5 Glenmark Pharmaceuticals Latest Developments

11.9 Merck

11.9.1 Merck Company Information

11.9.2 Merck HER2 Targeted Therapy Product Offered

11.9.3 Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Merck Main Business Overview

11.9.5 Merck Latest Developments

11.10 Roche

11.10.1 Roche Company Information

11.10.2 Roche HER2 Targeted Therapy Product Offered

11.10.3 Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Roche Main Business Overview

11.10.5 Roche Latest Developments

11.11 Novartis

11.11.1 Novartis Company Information

11.11.2 Novartis HER2 Targeted Therapy Product Offered

11.11.3 Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Novartis Main Business Overview

11.11.5 Novartis Latest Developments

11.12 Astra Zeneca

11.12.1 Astra Zeneca Company Information

11.12.2 Astra Zeneca HER2 Targeted Therapy Product Offered

11.12.3 Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Astra Zeneca Main Business Overview

11.12.5 Astra Zeneca Latest Developments

11.13 Daiichi Sankyo

11.13.1 Daiichi Sankyo Company Information

11.13.2 Daiichi Sankyo HER2 Targeted Therapy Product Offered

11.13.3 Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Daiichi Sankyo Main Business Overview

11.13.5 Daiichi Sankyo Latest Developments

12 Research Findings and Conclusion

Table 1. HER2 Targeted Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Monotherapy

Table 3. Major Players of Combination Therapy

Table 4. Major Players of Others

Table 5. HER2 Targeted Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global HER2 Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global HER2 Targeted Therapy Market Size Market Share by Type (2017-2022)

Table 8. HER2 Targeted Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global HER2 Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global HER2 Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 11. Global HER2 Targeted Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global HER2 Targeted Therapy Revenue Market Share by Player (2020-2022)

Table 13. HER2 Targeted Therapy Key Players Head office and Products Offered

Table 14. HER2 Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global HER2 Targeted Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global HER2 Targeted Therapy Market Size Market Share by Regions (2017-2022)

Table 19. Americas HER2 Targeted Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas HER2 Targeted Therapy Market Size Market Share by Country (2017-2022)

Table 21. Americas HER2 Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas HER2 Targeted Therapy Market Size Market Share by Type (2017-2022)

Table 23. Americas HER2 Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas HER2 Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 25. APAC HER2 Targeted Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC HER2 Targeted Therapy Market Size Market Share by Region (2017-2022)

Table 27. APAC HER2 Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC HER2 Targeted Therapy Market Size Market Share by Type (2017-2022)

Table 29. APAC HER2 Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC HER2 Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 31. Europe HER2 Targeted Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe HER2 Targeted Therapy Market Size Market Share by Country (2017-2022)

Table 33. Europe HER2 Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe HER2 Targeted Therapy Market Size Market Share by Type (2017-2022)

Table 35. Europe HER2 Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe HER2 Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa HER2 Targeted Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa HER2 Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa HER2 Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of HER2 Targeted Therapy

Table 44. Key Market Challenges & Risks of HER2 Targeted Therapy

Table 45. Key Industry Trends of HER2 Targeted Therapy

Table 46. Global HER2 Targeted Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global HER2 Targeted Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global HER2 Targeted Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global HER2 Targeted Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global HER2 Targeted Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global HER2 Targeted Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 52. GlaxoSmithKline Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 53. GlaxoSmithKline HER2 Targeted Therapy Product Offered

Table 54. GlaxoSmithKline HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. GlaxoSmithKline Main Business

Table 56. GlaxoSmithKline Latest Developments

Table 57. Bayer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 58. Bayer HER2 Targeted Therapy Product Offered

Table 59. Bayer Main Business

Table 60. Bayer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Bayer Latest Developments

Table 62. Abbott Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 63. Abbott HER2 Targeted Therapy Product Offered

Table 64. Abbott Main Business

Table 65. Abbott HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Abbott Latest Developments

Table 67. AbbVie Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 68. AbbVie HER2 Targeted Therapy Product Offered

Table 69. AbbVie Main Business

Table 70. AbbVie HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. AbbVie Latest Developments

Table 72. Pfizer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 73. Pfizer HER2 Targeted Therapy Product Offered

Table 74. Pfizer Main Business

Table 75. Pfizer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Pfizer Latest Developments

Table 77. Sanofi Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 78. Sanofi HER2 Targeted Therapy Product Offered

Table 79. Sanofi Main Business

Table 80. Sanofi HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Sanofi Latest Developments

Table 82. Agilent Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 83. Agilent HER2 Targeted Therapy Product Offered

Table 84. Agilent Main Business

Table 85. Agilent HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Agilent Latest Developments

Table 87. Glenmark Pharmaceuticals Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 88. Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered

Table 89. Glenmark Pharmaceuticals Main Business

Table 90. Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Glenmark Pharmaceuticals Latest Developments

Table 92. Merck Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 93. Merck HER2 Targeted Therapy Product Offered

Table 94. Merck Main Business

Table 95. Merck HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Merck Latest Developments

Table 97. Roche Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 98. Roche HER2 Targeted Therapy Product Offered

Table 99. Roche Main Business

Table 100. Roche HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Roche Latest Developments

Table 102. Novartis Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 103. Novartis HER2 Targeted Therapy Product Offered

Table 104. Novartis HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Novartis Main Business

Table 106. Novartis Latest Developments

Table 107. Astra Zeneca Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 108. Astra Zeneca HER2 Targeted Therapy Product Offered

Table 109. Astra Zeneca Main Business

Table 110. Astra Zeneca HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Astra Zeneca Latest Developments

Table 112. Daiichi Sankyo Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors

Table 113. Daiichi Sankyo HER2 Targeted Therapy Product Offered

Table 114. Daiichi Sankyo Main Business

Table 115. Daiichi Sankyo HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Daiichi Sankyo Latest Developments

List of Figures

Figure 1. HER2 Targeted Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global HER2 Targeted Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global HER2 Targeted Therapy Market Size Market Share by Type in 2021

Figure 7. HER2 Targeted Therapy in Breast Cancer

Figure 8. Global HER2 Targeted Therapy Market: Breast Cancer (2017-2022) & ($ Millions)

Figure 9. HER2 Targeted Therapy in Stomach Cancer

Figure 10. Global HER2 Targeted Therapy Market: Stomach Cancer (2017-2022) & ($ Millions)

Figure 11. HER2 Targeted Therapy in Head and Neck Cancer

Figure 12. Global HER2 Targeted Therapy Market: Head and Neck Cancer (2017-2022) & ($ Millions)

Figure 13. HER2 Targeted Therapy in Lung Cancer

Figure 14. Global HER2 Targeted Therapy Market: Lung Cancer (2017-2022) & ($ Millions)

Figure 15. HER2 Targeted Therapy in Ovarian Cancer

Figure 16. Global HER2 Targeted Therapy Market: Ovarian Cancer (2017-2022) & ($ Millions)

Figure 17. HER2 Targeted Therapy in Others

Figure 18. Global HER2 Targeted Therapy Market: Others (2017-2022) & ($ Millions)

Figure 19. Global HER2 Targeted Therapy Market Size Market Share by Application in 2021

Figure 20. Global HER2 Targeted Therapy Revenue Market Share by Player in 2021

Figure 21. Global HER2 Targeted Therapy Market Size Market Share by Regions (2017-2022)

Figure 22. Americas HER2 Targeted Therapy Market Size 2017-2022 ($ Millions)

Figure 23. APAC HER2 Targeted Therapy Market Size 2017-2022 ($ Millions)

Figure 24. Europe HER2 Targeted Therapy Market Size 2017-2022 ($ Millions)

Figure 25. Middle East & Africa HER2 Targeted Therapy Market Size 2017-2022 ($ Millions)

Figure 26. Americas HER2 Targeted Therapy Value Market Share by Country in 2021

Figure 27. Americas HER2 Targeted Therapy Consumption Market Share by Type in 2021

Figure 28. Americas HER2 Targeted Therapy Market Size Market Share by Application in 2021

Figure 29. United States HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 30. Canada HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 31. Mexico HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Brazil HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. APAC HER2 Targeted Therapy Market Size Market Share by Region in 2021

Figure 34. APAC HER2 Targeted Therapy Market Size Market Share by Application in 2021

Figure 35. China HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Japan HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. Korea HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 38. Southeast Asia HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. India HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. Australia HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. Europe HER2 Targeted Therapy Market Size Market Share by Country in 2021

Figure 42. Europe HER2 Targeted Therapy Market Size Market Share by Type in 2021

Figure 43. Europe HER2 Targeted Therapy Market Size Market Share by Application in 2021

Figure 44. Germany HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. France HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 46. UK HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. Italy HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 48. Russia HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region in 2021

Figure 50. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type in 2021

Figure 51. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application in 2021

Figure 52. Egypt HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 53. South Africa HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 54. Israel HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 55. Turkey HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 56. GCC Country HER2 Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 57. Americas HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 58. APAC HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 59. Europe HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Middle East & Africa HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 61. United States HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Canada HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 63. Mexico HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Brazil HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 65. China HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 66. Japan HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 67. Korea HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Southeast Asia HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 69. India HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Australia HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Germany HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 72. France HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 73. UK HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 74. Italy HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 75. Russia HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 76. Spain HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 77. Egypt HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 78. South Africa HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 79. Israel HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 80. Turkey HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 81. GCC Countries HER2 Targeted Therapy Market Size 2023-2028 ($ Millions)